Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Schuth Alexander O.
Relationship:   COFO and Secretary
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   187,341    

Indirect Shares

  523,749      
Direct Value   $3,883,579    

Indirect Value

  $10,857,317      
Total Shares   711,090      
Total Value   $14,740,896      


Denali Therapeutics Inc.
 $3,883,579 Denali Therapeutics Inc.
 $3,883,579
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    15    

     Stock price went up :

    0   
    2    
     Stock price went down :
    0   
    13    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -30.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Denali Therapeutics Inc. DNLI COFO and Secretary 2024-02-14 187,341 2024-02-14 523,749    Premium*  
* Premium Members only  

Records found :    90         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-01-03 4 A $0.00 $0 D/D 53,720 170,157 0 -
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-01-05 4 S $19.43 $193,756 I/I (9,972) 539,307 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-02-08 4 OE $0.68 $34,000 D/D 50,000 210,185 0 -
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-02-13 4 AS $17.29 $46,960 D/D (2,716) 207,469 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-02-14 4 AS $17.66 $355,460 D/D (20,128) 187,341 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2018-06-22 4 OE $5.28 $31,247 D/D 5,918 5,918 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2018-10-02 4 OE $5.28 $62,498 D/D 7,043 12,961 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2018-12-10 4 AS $20.18 $50,450 I/I (2,500) 682,589 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2018-12-11 4 AS $20.22 $50,550 I/I (2,500) 680,089 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2018-12-12 4 AS $20.80 $52,000 I/I (2,500) 677,589 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-01-09 4 AS $20.31 $50,775 I/I (2,500) 675,089 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-01-10 4 AS $19.99 $49,975 I/I (2,500) 672,589 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-01-11 4 AS $20.80 $52,000 I/I (2,500) 670,089 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-02-08 4 AS $18.11 $45,275 I/I (2,500) 667,589 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-02-11 4 AS $18.74 $47,622 I/I (2,500) 665,089 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-02-12 4 AS $19.73 $50,192 I/I (2,500) 662,589 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-03-11 4 AS $21.20 $52,635 I/I (2,475) 660,114 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-03-12 4 AS $22.40 $56,291 I/I (2,513) 657,601 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-03-13 4 AS $23.60 $60,387 I/I (2,512) 655,089 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-04-09 4 AS $28.17 $69,721 I/I (2,475) 652,614 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-04-10 4 AS $28.26 $71,017 I/I (2,513) 650,101 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-04-11 4 AS $27.73 $69,658 I/I (2,512) 647,589 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-05-09 4 AS $22.86 $57,150 I/I (2,500) 645,089 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-05-10 4 AS $22.19 $55,475 I/I (2,500) 642,589 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-05-13 4 AS $21.09 $52,725 I/I (2,500) 640,089 0 -

  90  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed